Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Canadian National Railway	CNI	1. avr 2025	98.62	+1.19
Canadian Natural Resources	CNQ	1. avr 2025	31.32	+1.69
Canadian Pacific Kansas City	CP	1. avr 2025	71.05	+1.20
Canadian Solar	CSIQ	1. avr 2025	8.73	+0.92
Candel Therapeutics	CADL	1. avr 2025	5.57	-1.42
Cango ADR	CANG	1. avr 2025	3.85	+1.58
Cannae	CNNE	1. avr 2025	18.66	+1.80
Canopy Growth	CGC	1. avr 2025	1.02	+12.09
Cantaloupe	CTLP	1. avr 2025	7.73	-1.78
Canterbury Park	CPHC	1. avr 2025	18.50	+1.37
Cantor Equity Partners	CEP	1. avr 2025	10.75	+0.09
Cantor Equity Partners I	CEPO	1. avr 2025	10.31	0.00
Capital Bancorp	CBNK	1. avr 2025	28.23	-0.35
Capital City Bank Group	CCBG	1. avr 2025	35.84	-0.33
Capital Clean Energy Carriers	CCEC	1. avr 2025	20.10	+4.47
Capital One Financial	COF	1. avr 2025	178.22	-0.60
Capital One Financial I Pref	COF-I	1. avr 2025	19.07	+0.47
Capital One Financial J Pref	COF-J	1. avr 2025	18.15	+0.06
Capital One Financial K Pref	COF-K	1. avr 2025	17.63	-0.11
Capital One Financial L Pref	COF-L	1. avr 2025	16.55	+0.67
Capital One Financial N Pref	COF-N	1. avr 2025	16.12	+0.12
Capital Southwest	CSWC	1. avr 2025	22.44	+0.54
Capitol Federal Financial	CFFN	1. avr 2025	5.63	+0.54
Capri Holdings	CPRI	1. avr 2025	19.36	-1.88
Capricor Therapeutics	CAPR	1. avr 2025	9.47	-0.16
Capstone Therapeutics	CAPS	1. avr 2025	2.34	0.00
Captivision	CAPT	1. avr 2025	0.50	+5.33
Cara Therapeutics	CARA	1. avr 2025	4.94	-2.56
Carbon Revolution	CREV	1. avr 2025	2.78	+4.91
Cardiff Oncology	CRDF	1. avr 2025	3.06	-2.55

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.